Insulin Resistance Under-Diagnosed in Non-Diabetics with Parkinson’s Disease

Findings could lead to increased screening for PD patients to detect and correct insulin resistance, reports the Journal of Parkinson’s Disease

August 3, 2018 - Amsterdam, NL – Almost two-thirds of non-diabetic patients with Parkinson’s disease (PD) may be insulin resistant, despite having normal blood sugar, report scientists in the Journal of Parkinson’s Disease. Their findings suggest that insulin resistance in PD is a common and largely undetected problem, especially in patients who are overweight. More...

August 3, 2018

Exenatide Treatment Alleviated Symptoms of Depression in Patients with Moderate Parkinson’s Disease

Post hoc analysis of PD trial results showed exenatide improved non-motor symptoms, including depression, according to a new report in the Journal of Parkinson’s Disease

August 1, 2018 - Amsterdam, NL – Non-motor symptoms of Parkinson’s disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life than motor deficits. In a post hoc analysis of the exenatide-PD trial results, investigators found that patients on exenatide treatment experienced improvements in severity of depression, independent of whether their motor function improved. More...

August 1, 2018

Naturalistic Driving Study Investigates Self-Regulation Behavior in Early Alzheimer’s Disease

A pilot study in the Journal of Alzheimer's Disease

July 27, 2018 - Lyon, FR – Driving is a complex task that involves perceptual, motor and cognitive abilities. These abilities may be affected in early Alzheimer's disease (AD) patients. Nevertheless, they continue to drive for more years than people with other dementia syndromes perhaps because of a deficit in self-awareness that prevents them from perceiving their driving difficulties and adapting accordingly. The purpose of the present pilot study was to closely examine the self-regulation behavior of older individuals with AD using a naturalistic driving approach. More...

July 27, 2018

Greg Kennedy Honored with 2018 Alzheimer Award

The award recognizes his outstanding contribution to the advancement of AD research published in the Journal of Alzheimer’s Disease

July 16, 2018 - Amsterdam, NL – The Journal of Alzheimer’s Disease (JAD) is pleased to announce that Greg Kennedy, a PhD candidate at the Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia, has been chosen as the recipient of the 2018 Alzheimer Award. More...

July 16, 2018